News

TipRanks on MSN4h

Regeneron’s Promising Phase 3 Trial for Lymphoma Treatment: What Investors Need to Know

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a Phase 3 ...
Cooper Academy on MSN19h

A Deep Look Into Cathie Wood's Portfolio (Ark Invest)

Explore Cathie Wood's investment strategy at Ark Invest. Discover her top stock picks like Tesla and CRISPR, and her focus on ...